Benzinga | Feb 24, 2021 04:07PM EST

Paratek Pharmaceuticals Q4 EPS $(0.54) Misses $(0.04) Estimate, Sales $16.00M Up From $8.97M YoY

Paratek Pharmaceuticals (NASDAQ:PRTK) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.04) by 1250 percent. This is a 33.33 percent increase over losses of $(0.81) per share from the same period last year. The company reported $16.00 million in sales this quarter. This is a 78.43 percent increase over sales of $8.97 million the same period last year.